Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > News > Anti-cancer nanotechnology - a two-pronged attack

August 1st, 2005

Anti-cancer nanotechnology - a two-pronged attack

Abstract:
Richard Jones: Drug delivery - and in particular the delivery of anti-cancer therapeutics - has emerged as one of the major applications of nanotechnology in medicine. There’s a nice brief review of the subject by Ruth Duncan in this month’s issue of Nano Today: - Nanomedicine gets clinical . An interesting paper in this week’s Nature reports a significant new development from Sasisekharan’s group at MIT, in which two drugs are combined in a single delivery system. This nanovector first selectively targets tumour tissue, then releases a drug which cuts off the blood supply to the tumour, isolating and starving it, and then releases a second drug which directly attacks the tumour cells.

Source:
Soft Machines

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014

Cloaked DNA nanodevices survive pilot mission: Successful foray opens door to virus-like DNA nanodevices that could diagnose diseased tissues and manufacture drugs to treat them April 22nd, 2014

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

Amino-functionalized carbon nanotubes act as a carrier for nerve growth factor April 21st, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE